Exact Mass: 606.2101
Exact Mass Matches: 606.2101
Found 291 metabolites which its exact mass value is equals to given mass value 606.2101
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Bruceantinol
Bruceantinol is a triterpenoid. Bruceantinol is a natural product found in Brucea javanica with data available.
Aurasperone B
Aurasperone B is a mycotoxin from Aspergillus niger, Aspergillus awamori and Aspergillus fonsecaeu
Phaeophorbide b
Phaeophorbide b is found in brassicas. Phaeophorbide b is a constituent of various plant species including Brassica species
1,5-Bis(4'-glucopyranosyloxy-3'-hydroxyphenyl)pent-4-en-1-yne
Asp-Asp-Asp-Asp-Lys
Pinocembrin 7-O-neohesperidoside 6-O-acetate
Pinocembrin 7-O-neohesperidoside 3-O-acetate
4,2,3,4-Tetrahydroxychalcone 4-O-(2-O-acetyl-6-O-cinnamoyl)glucoside
Skullcapflavone I 2-(2-E-cinnamoylglucoside)
Skullcapflavone I 2-(4-E-Cinnamoylglucoside)
skullcapflavone I 2-O-beta-D-(3-E-cinnamoyl)glucopyranoside|SkullcapflavoneI 2-O-??-D-(3-E-cinnamoyl)glucopyranoside
(3E,5E,7R,84S)-12c-acetoxy-14-chloro-10t,11c-epoxy-84-hydroxy-15,7r-dimethoxy-3,9c,11t,15-tetramethyl-(84rH,86cH)-15-aza-1(1,3)-benzena-8(4,6)-[1,3]oxazinana-cyclopentadecaphane-3,5-diene-82,14-dione|ansamitocin P1|C-15003 P-1,Maytanacin|Maytanacin (6)|Maytanacine|O3-acetyl-maytansinol
13-hydroxyblumenol C apiosyl-2-malonylglucoside|4-[3-(2-O-beta-apiofuranosyl-6-O-malonyl-beta-glucopyranosyloxy)-butyl]-3-(hydroxymethyl)-5,5-dimethyl-2-cyclohexen-1-one
6-Methoxy-3,4-(methylene(2-methyl-6-methoxy-1,2,3,4-tetrahydroisoquinoline-1,7-diyl)oxy(1-oxo-2-methyl-5,6-(epoxymethanoxy)-1,2-dihydro-3H-isoindole-4,3-diyl)methylene)(1,1-oxybisbenzene)
chrysoeriol-7-O-alpha-L-rhamnosyl-(1->6)-beta-D-glucoside|chrysoeriol-7-O-rutinoside
(E)-1,5-bis(4-beta-D-glucopyranosyloxy-3-hydroxyphenyl)pent-4-en-1-yne|(E)-1,5-bis-(4-beta-D-glucopyranosyloxy-3-hydroxyphenyl)pent-1-en-4-yne|hypoxoside
11,17-dimethoxy-18-(3,4,5-trimethoxy-benzoyloxy)-yohimb-19-ene-16-carboxylic acid methyl ester|11,17alpha-Dimethoxy-18beta-(3,4,5-trimethoxy-benzoyloxy)-3beta-yohimb-19-en-16beta-carbonsaeure-methylester|11,17alpha-dimethoxy-18beta-(3,4,5-trimethoxy-benzoyloxy)-3beta-yohimb-19-ene-16beta-carboxylic acid methyl ester|Raujemidin|Raujemidine.
Hepta-O-acetyl-beta-primverose|Primeverose-heptaacetat
1alpha,2alpha,6beta,13-tetraacetoxy-9alpha-benzoyloxy-4beta,6beta-dihydroxy-beta-dihydroagarofuran|ejaponine B
Asp Phe Tyr Tyr
Asp Met Arg Trp
Asp Met Trp Arg
Asp Arg Met Trp
Asp Arg Trp Met
Asp Thr Trp Trp
Asp Trp Met Arg
Asp Trp Arg Met
Asp Trp Thr Trp
Asp Trp Trp Thr
Asp Tyr Phe Tyr
Asp Tyr Tyr Phe
Glu Ser Trp Trp
Glu Trp Ser Trp
Glu Trp Trp Ser
Phe Asp Tyr Tyr
Phe Phe Met Tyr
Phe Phe Tyr Met
Phe Met Phe Tyr
Phe Met Tyr Phe
Phe Tyr Asp Tyr
Phe Tyr Phe Met
Phe Tyr Met Phe
Phe Tyr Tyr Asp
Met Asp Arg Trp
Met Asp Trp Arg
Met Phe Phe Tyr
Met Phe Tyr Phe
Met Met Tyr Tyr
Met Arg Asp Trp
Met Arg Trp Asp
Met Trp Asp Arg
Met Trp Arg Asp
Met Tyr Phe Phe
Met Tyr Met Tyr
Met Tyr Tyr Met
Arg Asp Met Trp
Arg Asp Trp Met
Arg Met Asp Trp
Arg Met Trp Asp
Arg Trp Asp Met
Arg Trp Met Asp
Ser Glu Trp Trp
Ser Trp Glu Trp
Ser Trp Trp Glu
Thr Asp Trp Trp
Thr Trp Asp Trp
Thr Trp Trp Asp
Trp Asp Met Arg
Trp Asp Arg Met
Trp Asp Thr Trp
Trp Asp Trp Thr
Trp Glu Ser Trp
Trp Glu Trp Ser
Trp Met Asp Arg
Trp Met Arg Asp
Trp Arg Asp Met
Trp Arg Met Asp
Trp Ser Glu Trp
Trp Ser Trp Glu
Trp Thr Asp Trp
Trp Thr Trp Asp
Trp Trp Asp Thr
Trp Trp Glu Ser
Trp Trp Ser Glu
Trp Trp Thr Asp
Tyr Asp Phe Tyr
Tyr Asp Tyr Phe
Tyr Phe Asp Tyr
Tyr Phe Phe Met
Tyr Phe Met Phe
Tyr Phe Tyr Asp
Tyr Met Phe Phe
Tyr Met Met Tyr
Tyr Met Tyr Met
Tyr Tyr Asp Phe
Tyr Tyr Phe Asp
Tyr Tyr Met Met
Aurasperone B
A dimeric naphthopyran with formula C32H30O12, isolated from several Aspergillus species.
Pheophorbide b
AI3-22370
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010277 - Parasympathomimetics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor D004791 - Enzyme Inhibitors
Protoporphyrin disodium
D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents C26170 - Protective Agent > C2081 - Hepatoprotective Agent D003879 - Dermatologic Agents
2-[(1E,3E)-5-(3,3-DIMETHYL-1-PHENYL-1,3-DIHYDRO-2H-INDOL-2-YLIDENE)-1,3-PENTADIENYL]-3,3-DIMETHYL-1-PHENYL-3H-INDOLIUM PERCHLORATE
(((9H-FLUORENE-9,9-DIYL)BIS(4,1-PHENYLENE))BIS(OXY))BIS(2-HYDROXYPROPANE-3,1-DIYL) DIACRYLATE
2,19-Methano-3,7:4,1-dimetheno-1H,11H-14,10,2,9,11,17-benzoxathiatetraazacyclodocosine-8,18(9H,15H)-dione, 27-cyclohexyl-12,13,16,17-tetrahydro-22-methoxy-11,17-dimethyl-, 10,10-dioxide
6-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]-5-hydroxy-7-methoxy-2-(4-methoxyphenyl)chromen-4-one
alpha-D-xylopyranosyl-(1->6)-[alpha-D-xylopyranosyl-(1->6)-beta-D-glucopyranosyl-(->4)]-beta-D-glucopyranose
(3S-(3alpha,4beta,21beta))-14-Ethyl-13-formyl-21-(methoxycarbonyl)-4,8,18-trimethyl-20-oxo-9-vinylphorbine-3-propionic acid
magnesium;(E)-3-[11,16-bis(ethenyl)-3-methoxycarbonyl-12,17,21,26-tetramethyl-4-oxido-23,25-diaza-7,24-diazanidahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,3,5,8(26),9,11,13(25),14,16,18,20(23),21-dodecaen-22-yl]prop-2-enoate
3-[(21S,22S)-16-ethenyl-11-ethyl-12-formyl-4-hydroxy-3-methoxycarbonyl-17,21,26-trimethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,3,5,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid
3-[(21S,22S)-11,16-bis(ethenyl)-4-hydroxy-12-(hydroxymethyl)-3-methoxycarbonyl-17,21,26-trimethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,3,5,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid
2-[2-hydroxy-4-[(E)-5-[3-hydroxy-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]pent-1-en-4-ynyl]phenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
3-[(12E)-16-ethenyl-11-ethyl-12-(hydroxymethylidene)-3-methoxycarbonyl-17,21,26-trimethyl-4-oxo-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,5(26),6,8,10,13(25),14,16,18(24),19-decaen-22-yl]propanoic acid
10-(2,5-dihydroxy-6,8-dimethoxy-2-methyl-4-oxo-3H-benzo[g]chromen-10-yl)-2,5-dihydroxy-6,8-dimethoxy-2-methyl-3H-benzo[g]chromen-4-one
N-[(2S,3S)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide
6-[(3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]-5-hydroxy-7-methoxy-2-(4-methoxyphenyl)chromen-4-one
(1S)-N-(4-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-(3-methylphenyl)sulfonyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]carboxamide
(1R)-N-(4-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-(3-methylphenyl)sulfonyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]carboxamide
N-[(2R,3S)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide
N-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide
N-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide
N-[(2R,3R)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide
N-[(2S,3R)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide
N-[(2R,3S)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide
N-[(2R,3R)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide
N-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide
N-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide
N-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide
1-[(2R,3S)-2-[[(4-chlorophenyl)sulfonyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-cyclohexylurea
N-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide
N-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide
N-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide
3-[18-(2-carboxylatoethyl)-3,7,7,8,12,13,17-heptamethyl-8H-porphyrin-21,23-diid-2-yl]propanoate;iron
(2S,3R,4S,5R,6R)-6-[[(3R,5R,8S,9S,10S,13S,14S,17R)-17-carboxy-17-hydroxy-10,13-dimethyl-11-oxo-2,3,4,5,6,7,8,9,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3,5-dihydroxy-4-sulfooxyoxane-2-carboxylic acid
[1-acetyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
iron methylchlorin(2-)
A dicarboxylic acid dianion resulting from the removal of a proton from both of the carboxy groups of iron methylchlorin. Major species at pH 7.3.
A-317491 (sodium salt hydrate)
A-317491 sodium salt hydrate is a potent, selective and non-nucleotide antagonist of P2X3 and P2X2/3 receptors, with Kis of 22, 22, 9, and 92 nM for hP2X3, rP2X3, hP2X2/3, and rP2X2/3, respectively. A-317491 sodium salt hydrate is highly selective (IC50>10 μM) over other P2 receptors and other neurotransmitter receptors, ion channels, and enzymes. A-317491 sodium salt hydrate reduces inflammatory and neuropathic pain by blocking P2X3 and P2X2/3 receptor-mediated calcium flux[1][2].